Livzon Pharma files list of board and committee members with disclosure duties

• Livzon Pharmaceutical Group disclosed its current board lineup, led by Chairman-President Liu Daping; Tang Yanggang serves as vice chairman.
• Five board committees were confirmed: audit, remuneration and appraisal, nomination, strategy, environmental, social and governance.
• Kang Li chairs the audit committee; Cui Lijie chairs the remuneration and appraisal committee; Luo Huiyuan chairs the nomination committee.
• Liu Daping chairs the strategy committee, chairs the environmental, social and governance committee.
• Committee memberships include Tang Yanggang across four committees; Ran Yongmei sits on the strategy committee; Wang Zhiyao sits on ESG.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Livzon Pharmaceutical Group Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260911-12330082), on September 11, 2026, and is solely responsible for the information contained therein.